- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03722771
Influence of Lavender Oil on Vital Signs in Oral Surgery Patients
June 9, 2020 updated by: Nazife Begüm KARAN
Influence of Lavender Oil on Vital Signs and Anxiety in Oral Surgery Patients: a Randomized Controlled Clinical Trial
The aim of this study is to investigate the impact of lavender oil (Lavandula angustifolia) on anxiety, mood, vital signs (blood pressure, respiratory rate, heart rate and saturation) for oral surgery patients.
Study Overview
Status
Completed
Conditions
Detailed Description
Lavender oil has sedative properties.
Oral surgical procedures have been proven as to be the greatest concern among dental practices for patients.
Limited randomized clinical trials have demonstrated evidence-based results of lavender oil, despite being the most effective essential oil for anxiety and stress.
The hypothesis of the present study was that the inhalation of lavender oil prior to oral surgical procedures may reduce anxiety and consequently may effect intra and post-operative blood pressure, inspiration and heart rate.
Study Type
Interventional
Enrollment (Actual)
126
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Merkez
-
Ri̇ze, Merkez, Turkey, 053100
- Nazife Begüm Karan
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 37 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Clinical diagnosis of wisdom tooth
- Must be similar in age-height-weight
- Must be similar socio-culturally
Exclusion Criteria:
- Under 18 years of age
- Taking psychotropic medication or psychiatric treatment
- Systemically unhealthy patients
- Pregnants
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: lavender oil group (A)
100 % pure, high strength lavender oil inhalation in a separate room for 3 minutes, prior to surgery. Anxiety questionnaires 1 (MDAS) Anxiety questionnaires 2 (STAI-S) Vital signs 1 (Blood pressure) Vital signs 2 (respiratory rate,) Vital signs 3 (heart rate) Vital signs 4 (saturation) |
lavender oil inhalation in a separate room for 3 minutes prior to surgery
Other Names:
Modified Dental Anxiety Scale was used to describe the level of the dental anxiety.
Other Names:
State-Trait Anxiety Inventory-State Scale was used to distinguish the true anxiety level of the patients from the anxiety level for a particular situation.
Other Names:
Changes in vital signs 1 - blood pressure - before, during and after the procedure were noted.
Other Names:
Changes in vital signs 2 - respiratory rate - before, during and after the procedure were noted.
Other Names:
Changes in vital signs 3 - heart rate - before, during and after the procedure were noted.
Other Names:
Changes in vital signs 4 - saturation - before, during and after the procedure were noted.
Other Names:
|
|
Sham Comparator: control group (B)
No application of lavender oil, prior to surgery.
Anxiety questionnaires 1 (MDAS) Anxiety questionnaires 2 (STAI-S) Vital signs 1 (Blood pressure) Vital signs 2 (respiratory rate,) Vital signs 3 (heart rate) Vital signs 4 (saturation)
|
Modified Dental Anxiety Scale was used to describe the level of the dental anxiety.
Other Names:
State-Trait Anxiety Inventory-State Scale was used to distinguish the true anxiety level of the patients from the anxiety level for a particular situation.
Other Names:
Changes in vital signs 1 - blood pressure - before, during and after the procedure were noted.
Other Names:
Changes in vital signs 2 - respiratory rate - before, during and after the procedure were noted.
Other Names:
Changes in vital signs 3 - heart rate - before, during and after the procedure were noted.
Other Names:
Changes in vital signs 4 - saturation - before, during and after the procedure were noted.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Vital Sign Measurements - 1 - changes in blood pressure
Time Frame: through study completion an average of 3 months
|
changes in blood pressure
|
through study completion an average of 3 months
|
|
Vital Sign Measurements - 2 - changes in respiratory rate
Time Frame: through study completion an average of 3 months
|
changes in respiratory rate
|
through study completion an average of 3 months
|
|
Vital Sign Measurements - 3 - changes in heart rate
Time Frame: through study completion an average of 3 months
|
changes in heart rate
|
through study completion an average of 3 months
|
|
Vital Sign Measurements - 4 - changes in saturation level
Time Frame: through study completion an average of 3 months
|
changes in saturation level
|
through study completion an average of 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anxiety Test 1 - MDAS tests
Time Frame: through study completion an average of 3 months
|
MDAS tests
|
through study completion an average of 3 months
|
|
Anxiety Test 2 - STAI-S tests
Time Frame: through study completion an average of 3 months
|
STAI-S tests
|
through study completion an average of 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Nazife Begüm KARAN, Recep Tayyip Erdoğan University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2017
Primary Completion (Actual)
November 2, 2018
Study Completion (Actual)
November 2, 2018
Study Registration Dates
First Submitted
October 22, 2018
First Submitted That Met QC Criteria
October 25, 2018
First Posted (Actual)
October 29, 2018
Study Record Updates
Last Update Posted (Actual)
June 11, 2020
Last Update Submitted That Met QC Criteria
June 9, 2020
Last Verified
June 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 106
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dental Anxiety
-
Aga Khan University Hospital, PakistanDow University of Health Sciences; Civil Hospital KarachiCompletedDental Anxiety | Dental Fear and AnxietyPakistan
-
Riham AbbasRecruitingDental Anxiety | Dental Fear | Dental Fear and AnxietyEgypt
-
University of PaviaCompletedDental Anxiety | Dental PhobiaItaly
-
Cairo UniversityUnknownAnxiety, Dental | Fear, Dental
-
Universidade Federal do Rio Grande do NorteCompletedDental Anxiety | Dental Fear and AnxietyBrazil
-
Alexandria UniversityNot yet recruitingPediatric Dental Anxiety | Pediatric Dental PainEgypt
-
Ataturk UniversityScientific Research Projects Coordınatıon Unit of Atatürk UniversityRecruiting
-
Selcuk UniversityCompleted
-
St. Justine's HospitalRecruitingDental Anxiety | Dental Trauma | Dental Diseases | Dental PhobiaCanada
-
St. Justine's HospitalCompletedDental Anxiety | Dental Trauma | Dental Diseases | Dental PhobiaCanada
Clinical Trials on Inhalation
-
Peking University First HospitalCompletedPostoperative Complications | Long-term OutcomeChina
-
Kaohsiung Medical University Chung-Ho Memorial...OTA HYDROGEN SOLUTIONS LTD.RecruitingQuality of Life | Pain | Head and Neck Cancer | Sleep | Inhalation; GasTaiwan
-
Haisco Pharmaceutical Group Co., Ltd.Active, not recruiting
-
University Hospital, Basel, SwitzerlandRecruitingOverweight and ObesitySwitzerland
-
Olga TyuminaClinics of the Federal State Budgetary Educational Institution SSMU; Samara...UnknownCOVID-19 | Covid19 | SARS-CoV-2 PNEUMONIARussian Federation
-
Uskudar UniversityNot yet recruitingRespiratory Tract Diseases | Respiratory Infections, Acute
-
Air Liquide SAAsklepios Kliniken Hamburg GmbHTerminatedPulmonary Disease, Chronic ObstructiveGermany
-
University of Roma La SapienzaQueen Mary University of London; Università degli studi di Roma Foro Italico; Bios Prevention SrlCompletedPost Acute Sequelae of COVID-19 | Post COVID-19 Condition | Long-COVID | Chronic COVID-19 SyndromeItaly
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.CompletedPulmonary Disease, Chronic ObstructiveChina
-
Karolinska InstitutetCompletedThrombosis | Vascular Function | Microcirculation | Heated Tobacco Products | Blood Markers | Microvesicles | NETsSweden